APA

Delmas P. D., Benhamou C. L., Man Z., Tlustochowicz W., Matzkin E., Eusebio R., Zanchetta J., Olszynski W. P., Recker R. R. & McClung M. R. (20090113). Monthly dosing of 75 mg risedronate on 2 consecutive days a month: efficacy and safety results. : Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA.

Chicago

Delmas P D, Benhamou C L, Man Z, Tlustochowicz W, Matzkin E, Eusebio R, Zanchetta J, Olszynski W P, Recker R R and McClung M R. 20090113. Monthly dosing of 75 mg risedronate on 2 consecutive days a month: efficacy and safety results. : Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA.

Harvard

Delmas P. D., Benhamou C. L., Man Z., Tlustochowicz W., Matzkin E., Eusebio R., Zanchetta J., Olszynski W. P., Recker R. R. and McClung M. R. (20090113). Monthly dosing of 75 mg risedronate on 2 consecutive days a month: efficacy and safety results. : Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA.

MLA

Delmas P D, Benhamou C L, Man Z, Tlustochowicz W, Matzkin E, Eusebio R, Zanchetta J, Olszynski W P, Recker R R and McClung M R. Monthly dosing of 75 mg risedronate on 2 consecutive days a month: efficacy and safety results. : Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 20090113.